Perbedaan Morenzo Abadi Perkasa Tbk. dan Indofarma Tbk.: Morenzo Abadi Perkasa Tbk. diperdagangkan di Rp78 (kapitalisasi pasar 162,19 M, volume 24 jam 121,54 jt), sedangkan Indofarma Tbk. diperdagangkan di Rp126 (kapitalisasi pasar 390,51 M). Perbedaan utamanya: Indofarma Tbk. jauh lebih besar — sekitar 2,4× kapitalisasi pasar Morenzo Abadi Perkasa Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| ENZO | INAF | |
|---|---|---|
Kapitalisasi Pasar | 162,19 M | 390,51 M |
Volume | 121,54 jt | — |
Lot | 1,22 jt | — |
Perputaran | 9,5 M | — |
Harga Rata-rata | 78,21 | — |
Nilai Transaksi | 9,5 M | — |
Harga Ekuilibrium Indikatif | 78 | — |
Volume Ekuilibrium Indikatif | 28,2 rb | — |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Morenzo Abadi Perkasa Tbk, (The “Company”) was established based on Notarial Deed No. 21 of Jhon Langsung, S.H., dated January 10, 2013. Company commenced its commercial business activities in 2013. PT Tritunggal Sukses Investama is the ultimate Parent Entity and Parent Entity of the Company and Mr. Markus Silitonga as the ultimate shareholder.
Selengkapnya di halaman ENZO →PT Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk (the Company) was established based on Deed No. 1 dated January 2, 1996 as amended by Deed No. 134 dated January 26, 1996 both of Notary Sutjipto, SH. PT. Indofarma, Tbk began as medicine factory well known as "Pabrik Obat Manggarai". Then take over by Japan's Government from Nederland's Government on 1942. On 1950 the Indonesian Government acquisited the factory by Department of Health and functioned as center of pharmacy production for its department. On 1979 the name changed to be Department of Health Center of Pharmacy Production as non Profit institution as main assignment to produced medicine for public service. Then the Company changed the name as PT. Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk.
Selengkapnya di halaman INAF →